Intuitive Surgical, Inc. $ISRG Position Trimmed by Westwind Capital

Westwind Capital decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 21,072 shares of the medical equipment provider’s stock after selling 1,610 shares during the period. Intuitive Surgical comprises 2.1% of Westwind Capital’s portfolio, making the stock its 17th largest holding. Westwind Capital’s holdings in Intuitive Surgical were worth $8,569,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the stock. North Point Portfolio Managers Corp OH acquired a new position in Intuitive Surgical in the 3rd quarter valued at approximately $27,000. Main Street Group LTD acquired a new position in shares of Intuitive Surgical in the first quarter worth $30,000. Compass Financial Management LLC purchased a new stake in shares of Intuitive Surgical during the second quarter worth $30,000. Vermillion Wealth Management Inc. raised its holdings in shares of Intuitive Surgical by 58.1% during the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after acquiring an additional 25 shares in the last quarter. Finally, Motiv8 Investments LLC acquired a new stake in Intuitive Surgical during the fourth quarter valued at $34,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Intuitive Surgical news, Director Gary Guthart sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total value of $4,000,000.00. Following the sale, the director owned 1,245,679 shares of the company’s stock, valued at $498,271,600. This trade represents a 0.80% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 1,089 shares of the firm’s stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $374.44, for a total value of $407,765.16. Following the completion of the sale, the vice president directly owned 1,026 shares in the company, valued at $384,175.44. This trade represents a 51.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 12,370 shares of company stock worth $4,891,989 over the last 90 days. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Multiple analyst endorsements support investor sentiment. Piper Sandler issued a Buy rating, while Barclays upgraded Intuitive Surgical to Strong Buy after initiating coverage at Overweight. Citi had also assigned a Buy rating. These actions suggest analysts view the company as a high-quality medical-device leader despite a softer industry backdrop. Piper Sandler Buy rating Barclays coverage
• Positive Sentiment: Growth in the da Vinci SP platform is a key catalyst. Rising procedure volumes, system utilization and placements, along with expanding indications and international adoption, could make the single-port platform an important future revenue franchise. Single-port platform growth
• Positive Sentiment: Investors are anticipating further operating growth. Analysts expect year-over-year increases in earnings and revenue ahead of Intuitive Surgical’s October 20 earnings release. The company’s latest reported quarter already exceeded consensus earnings and revenue estimates. Barclays bullish initiation
• Neutral Sentiment: Analyst optimism should be viewed cautiously. Intuitive Surgical’s favorable average brokerage recommendation may be supportive, but sell-side ratings can be overly optimistic and the stock’s elevated valuation leaves less room for disappointing results. Analyst recommendation analysis
• Negative Sentiment: Competition remains the principal risk. Commentary from Jim Cramer highlighted increasing competition, particularly from Johnson & Johnson, raising concerns that rivals could pressure Intuitive Surgical’s dominant position and valuation. Competition commentary

Analyst Upgrades and Downgrades

A number of brokerages have commented on ISRG. BTIG Research restated a “buy” rating and issued a $469.00 target price on shares of Intuitive Surgical in a research note on Tuesday, September 8th. Raymond James Financial reiterated an “outperform” rating and set a $483.00 price target (down from $577.00) on shares of Intuitive Surgical in a report on Friday, July 17th. Leerink Partners lowered their price target on Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating for the company in a research note on Friday, July 17th. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Sunday, September 20th. Finally, Evercore set a $430.00 price target on shares of Intuitive Surgical in a research note on Monday, July 6th. One investment analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $502.53.

Intuitive Surgical Trading Up 0.2%

ISRG traded up $0.89 during trading on Thursday, hitting $415.41. The stock had a trading volume of 2,530,203 shares, compared to its average volume of 2,423,688. The firm has a market cap of $146.76 billion, a PE ratio of 47.58, a P/E/G ratio of 3.05 and a beta of 1.46. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88. The company has a 50 day simple moving average of $384.95 and a 200-day simple moving average of $411.17.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.48 by $0.32. The company had revenue of $2.89 billion during the quarter, compared to analysts’ expectations of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.81 earnings per share. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.